HCP
SEM

Hexagon Capital Partners’s Select Medical SEM Stock Holding History

Hexagon Capital Partners’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-743
Closed -$12.4K – 1418
2025
Q1 		$12.4K Buy
743
+116
+19% +$2.13K ﹤0.01% 909
2024
Q4 		$11.8K Sell
627
-654
-51% -$12.6K ﹤0.01% 958
2024
Q3 		$24.1K Sell
1,281
-143
-10% -$2.74K ﹤0.01% 648
2024
Q2 		$26.9K Buy
1,424
+1,198
+530% +$20.4K 0.01% 582
2024
Q1 		$3.68K Buy
226
+7
+3% +$102 ﹤0.01% 1046
2023
Q4 		$2.77K Sell
219
-33
-13% -$416 ﹤0.01% 1073
2023
Q3 		$3.44K Sell
252
-10
-4% -$154 ﹤0.01% 974
2023
Q2 		$4.49K Buy
262
+23
+10% +$356 ﹤0.01% 924
2023
Q1 		$3.33K Buy
239
+111
+87% +$1.63K ﹤0.01% 963
2022
Q4 		$1.71K Buy
128
+100
+357% +$1.29K ﹤0.01% 1113
2022
Q3 		$0 Buy
+28
New +$398 ﹤0.01% 1420

Other funds holding SEM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Hexagon Capital Partners's SEM Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Select Medical (SEM) in Q2 2025, closing a stake of 743 shares — an estimated $12.4K sold.

Hexagon Capital Partners first reported a position in SEM in Q3 2022 and held it in 11 quarters. The position peaked at $26.9K in Q2 2024. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 743 Select Medical shares in Q2 2025, an estimated $12.4K.
  • Hexagon Capital Partners first reported a position in Select Medical in Q3 2022 and held it in 11 quarters.
  • Hexagon Capital Partners's Select Medical position peaked at $26.9K in Q2 2024.
  • 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.